Education of Murine NK Cells Requires Both cis and trans Recognition of MHC Class I Molecules. by Bessoles, S. et al.
of September 17, 2020.
This information is current as
Molecules
 Recognition of MHC Class Itrans and cis
Education of Murine NK Cells Requires Both
Georges Leclercq, Eric Vivier and Werner Held











, 20 of which you can access for free at: cites 39 articlesThis article 
        average*
   
 4 weeks from acceptance to publicationFast Publication! •  
   
 Every submission reviewed by practicing scientistsNo Triage! •  
   
 from submission to initial decisionRapid Reviews! 30 days* •  
   
Submit online. ?The JIWhy 
Subscription
http://jimmunol.org/subscription
 is online at: The Journal of ImmunologyInformation about subscribing to 
Permissions
http://www.aai.org/About/Publications/JI/copyright.html
Submit copyright permission requests at: 
Email Alerts
http://jimmunol.org/alerts
Receive free email-alerts when new articles cite this article. Sign up at: 
Print ISSN: 0022-1767 Online ISSN: 1550-6606. 
Immunologists, Inc. All rights reserved.
Copyright © 2013 by The American Association of
1451 Rockville Pike, Suite 650, Rockville, MD 20852
The American Association of Immunologists, Inc.,































The Journal of Immunology
Education of Murine NK Cells Requires Both cis and trans
Recognition of MHC Class I Molecules
Stéphanie Bessoles,*,1 Georgi S. Angelov,* Jonathan Back,*,2 Georges Leclercq,†
Eric Vivier,‡ and Werner Held*
Although NK cells use invariant receptors to identify diseased cells, they nevertheless adapt to their environment, including the
presence of certain MHC class I (MHC-I) molecules. This NK cell education, which is mediated by inhibitory receptors specific for
MHC-I molecules, changes the responsiveness of activating NK cell receptors (licensing) and modifies the repertoire of MHC-I
receptors used by NK cells. The fact that certain MHC-I receptors have the unusual capacity to recognize MHC-I molecules
expressed by other cells (trans) and by the NK cell itself (cis) has raised the question regarding possible contributions of the
two types of interactions to NK cell education. Although the analysis of an MHC-I receptor variant suggested a role for cis
interaction for NK cell licensing, adoptive NK cell transfer experiments supported a key role for trans recognition. To reconcile
some of these findings, we have analyzed the impact of cell type–specific deletion of an MHC-I molecule and of a novel MHC-I
receptor variant on the education of murine NK cells when these mature under steady-state conditions in vivo. We find that MHC-I
expression by NK cells (cis) and by T cells (trans), and MHC-I recognition in cis and in trans, are both needed for NK cell
licensing. Unexpectedly, modifications of the MHC-I receptor repertoire are chiefly dependent on cis binding, which provides
additional support for an essential role for this unconventional type of interaction for NK cell education. These data suggest that
two separate functions of MHC-I receptors are needed to adapt NK cells to self–MHC-I. The Journal of Immunology, 2013, 191:
5044–5051.
N
atural killer cells can rapidly respond to infection, to
transformed cells, and to bone marrow grafts based on
the recognition of aberrations in the expression of “self.”
Detectable aberrations include both the loss of inhibitory ligands
(indicating infection or cellular transformation) and the upregu-
lation of activating ligands (indicating cell stress). Most normal
host cells do also activate NK cells, but these are not killed be-
cause of the inhibitory effect of MHC-I molecules. Consequently,
reduced MHC-I expression may be sufficient to render host cells
susceptible to NK cell–mediated attack, which is known as
“missing–self-recognition” (1).
Despite the use of innate recognition receptors to detect diseased
host cells, NK cells can adapt both phenotypically and functionally
to their environment. Most prominently, NK cells adapt to the pre-
sence of MHC-I molecules, which is globally referred to as NK
cell education. Murine NK cells recognize MHC-I using Ly49
family receptors and CD94/NKG2A, which bind certain classical
MHC-I alleles and the invariant Qa-1b, respectively. Individual
MHC-I receptors are expressed randomly and define subsets of 5–
50% of NK cells that overlap partially (2). A first aspect of NK cell
education is that the expression of MHC-I molecules, or the
enforced expression of a transgenic MHC-I receptor, modifies
MHC-I receptor usage by NK cells (3–5). The precise role of these
repertoire modifications is still unclear. Indeed, repertoire changes
do not guarantee that each NK cell expresses an inhibitory receptor
specific for self–MHC-I. Consequently, NK cells lacking inhibitory
receptors for autologous MHC-I represent a significant fraction of
the peripheral NK cell pool (6). A second aspect of NK cell edu-
cation is the functional adaptation to MHC-I.
Self-tolerance of the above NK cells lacking inhibitory receptors
for autologous MHC-I is ensured by their hyporesponsiveness to
stimulation (6). In contrast, NK cells that recognize autologous
MHC-I respond efficiently to stimulation via activation receptors
(6–9). The MHC-I–dependent effect on the function of NK cell
activation receptors is termed licensing (10). Although licensing
depends on ITIM present in the intracellular portion of inhibitory
MHC-I receptors (7, 9) (this study), the precise basis for licensing
is debated (11, 12). A “disarming” model suggests that the absence
of inhibitory interactions results in the continuous stimulation of
NK cells, which eventually induces a state of hyporesponsiveness
(13). This model requires only that inhibitory receptors inhibit NK
cells via their ITIMs. Alternatively, an “arming” model proposes
that engaged MHC-I receptors instruct NK cell activation receptors
to become responsive (7, 8). This model implies that ITIMs have
two distinct functions: arming and effector inhibition.
Members of the murine Ly49 and the human leukocyte Ig–like
receptor families have the highly unusual ability to bind MHC-I
expressed by other cells (trans) and by the NK cell itself (cis) (14–
17). Although the former mediates NK cell inhibition, there is no
evidence that cis binding inhibits the effector response (14).
Rather cis binding sequesters inhibitory receptors and renders
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them unavailable for trans binding, thereby facilitating effector
responses (9). To address the importance of the two types of
interactions for NK cell education, we previously generated a vari-
ant of the Ly49A receptor, which retained binding to its high-affinity
H-2Dd ligand in trans but failed to bind in cis. This receptor variant
inhibited the NK cell effector response but failed to license NK cells
(9). This outcome was inconsistent with the disarming model and
suggested a role for cis interaction for NK cell licensing. However,
adoptive transfers of functionally mature NK cells into MHC-I–
deficient hosts resulted in a rapid loss of NK cell function (18),
which strongly supported the disarming model. Moreover, adoptive
transfers of MHC-I–deficient NK cells into MHC-I–sufficient hosts
showed that MHC-I gene expression by NK cells was not required
to improve the function of NK cells (18, 19), which called into
question a role of cis recognition for NK cell education.
To reconcile some of these findings, we analyzed the impact of NK
cell– and T cell–specific H-2Dd deficiency and of a novel Ly49A
receptor variant on the function of NK cells that mature under
steady-state conditions in vivo. These systems revealed that MHC-I
expression by NK cells and by other cells, and MHC-I recognition
in cis and in trans, are all essential for the normal function of NK
cells. The finding that modifications of the MHC-I receptor reper-
toire are chiefly dependent on cis binding provides further support
for an essential role for this unconventional type of interaction for
the education of NK cells.
Materials and Methods
Mice
B6.DBA/2Tg(Ly49ABALB16)Whe (Ly49A Tg), B6.DBA/2Tg(Ly49-
72ABALB30)Whe (Ly49-72ATg), and B6.DBA/2Tg(Ly49A-Y8FBALB15)Whe
(Ly49A-Y8F Tg) mice were all generated using the BALB allele of Ly49A (9).
B6.DBA/2Tg(H-2Ddflox28)Whe (H-2Dd) transgenic (Tg) mice, containing a
floxed H-2Dd gene, B6.Cg-Tg(Cd4-cre)1Cwi (CD4-Cre Tg), and B6
Ncr1tm1.1(icre)Viv (Ncr-Cre knockin mice) have been described previously
(20–22). C57BL/6 (B6) and b2-microglobulin (b2m)-deficient B6 mice
(B6.129P2-B2mtm1Unc/J) were purchased from The Jackson Laboratory.
Ly49A Δa1 Tg mice were generated by removing aa 70–90 of the stalk
region (a1s segment) of Ly49ABALB (23), subcloning the cDNA into a mod-
ified pHSE cassette (24), and injecting the construct into fertilized (B6 3
DBA/2)F1 3 B6) oocytes. A Tg line (number 9) was established by back-
crossing (bc) to B6 (H-2b) mice. For the experiments shown in this paper,
Ly49A Da1 Tg mice were B6 bc . 5, Ly49Awild-type (Wt) and Ly49-72A
Tg mice were B6 bc 7-9, and Y8F Tg mice were B6 bc 5-6. All mice used
were homozygous for NK and H-2 complexes of B6 origin. Animal experi-
mentation followed protocols approved by the Service Vétérinaire de l’Etat
de Vaud.
Generation of mixed bone marrow chimeras
Dd mice were injected i.p. with 200 mg mAb PK136 (anti-NK1.1) to deplete
NK1.1+ cells. They were irradiated (two doses of 450 rad 4 h apart from a
137Cs source) 1 d later and reconstituted with various mixtures of T cell–
depleted Dd and CD4-Cre Dd bone marrow (BM) (4 3 106 cells total) the
following day. Recipients were allowed to engraft for .8 wk before analysis.
Cell lines
The cell lines used in this paper, C1498 (H-2b), RMA (H-2b), RMA/S
(MHC-Ilow), and Dd-transfected C1498 and RMA cells, have been de-
scribed previously (14).
NK cell culture and lysis assays
Nylon wool nonadherent splenocytes were cultured in complete DMEM plus
0.5 mg/ml recombinant human IL-2 (a gift from N. Rufer, University of
Lausanne). After 5 d, plastic–adherent cells were harvested and used as
effectors. C1498- and C1498 Dd–transfected tumor cells (14) were used as
target cells in standard Cr release assays.
Flow cytometry
Nylon wool nonadherent splenocytes were incubated with mAb 2.4G2
(CD16/32) hybridoma supernatant before staining with mixtures of biotin,
FITC, or PE-labeled Ly49 or CD94/NKG2 mAbs: A1 (Ly49AB6); JR9-318
(Ly49A); 4D12 (Ly49C/E) (note: Ly49E is expressed by ,1% of adult NK
cells) (25); 4E5 (Ly49D), HBF (Ly49F); 4D11 (Ly49G2); YLI90 (Ly49I);
18D3 (CD94); 20D5 (NKG2A/C/E); 16A11 (NKG2AB6); and 14B11 (Ly49C,
F,I,H), followed by streptavidin-PECy7/CD3-allophycocyanin Alexa780 and
NK1.1-PerCP-Cy5.5. Alternatively, NK1.1-PerCPCy5.5 and CD3-APC were
used in conjunction with PE-labeled H-2Dd multimer.
For IFN-g assays, spleen cells (5 3 106/ml) from unprimed mice were
stimulated with plastic-bound NK1.1 (5–10 mg/ml) (7) or PMA (50 ng/ml)
and ionomycin (1 mg/ml). After 1 h, GolgiPlug and GolgiStop (BD Bio-
sciences) were added. After 9 h, the cells were harvested and stained for
flow cytometry.
Spleen cells (6 3 106) from polyinosinic-polycytidylic acid (poly IC)–
activated NK cells were exposed to RMA (H-2b), RMA/S (MHC-Ilow) or
RMA Dd cells (6 3 106) or to mAb-coated plates for 4 h. Anti–lysosome-
associated membrane protein (LAMP-1) mAb was added to the cultures,
and GolgiPlug and GolgiStop were added after 1 h. After 4 h, cultures
were stained for flow cytometry.
Cells were analyzed on a FACSCanto flow cytometer with CellQuest
Pro Software (BD Biosciences). Acid treatment of primary NK cells was
done as described previously (14).
In vivo target cell rejection
Mice were injected i.p. with 100 mg poly IC (Sigma-Aldrich) 24 h before a 1:1
mixture of H-2b (labeled 3.0 mM CFSE [Molecular Probes]) and H-2bDd
splenocytes (labeled with 0.3 mM CFSE [2 3 107 cells total]). In some
experiments, CMTMR (2.5 mM; Invitrogen)-labeled b2m-knockout spleno-
cytes were added. Recipient spleens were analyzed 24 h later for the presence
of transferred cells. The percentage of specific rejection was calculated as
follows: 100 2 [(percentage of H-2b cells (CFSEhi)final/percentage of Dd
cells (CFSElow)final)/(percentage of H-2b cells (CFSEhi)initial/percentage
of Dd cells (CFSElow)initial)] 3 100.
Statistical analysis
Statistical significance was determined using ANOVA or a two-tailed
Student t test with equal sample variance. Data sets were considered sig-
nificantly different when p , 0.05.
Results
NK cell function in mice with cell type–specific H-2Dd ablation
To address the roles for cis versus trans recognition for NK cell
education, we specifically ablated H-2Dd expression in cis (NK
cells) or in trans (T cells). T cells were chosen as the trans-pre-
senting cell type because they are known NK cell targets in vivo
(26, 27). To generate cell type–selective Dd deficiency, we com-
bined a floxed H-2Dd (Dd) Tg (20) with NK cell or T cell–specific
Cre expression using Ncr-Cre knockin and CD4-Cre Tg mice,
respectively (21, 22). As expected, surface expression of H-2Dd
was absent from essentially all T cells in CD4-Cre Dd mice (Fig.
1A), whereas B cells, all myeloid cells, dendritic cells, and NK
cells faithfully expressed H-2Dd (Fig. 1A). In Ncr-Cre Dd mice,
H-2Dd was present on all T cells, B cells, and myeloid cells but
absent from most NK cells. However, ∼15% of NK cells were H-2Dd
positive (Fig. 1A). Most of these NK cells expressed the H-2Dd–
specific Ly49A receptor (Fig. 1B). On the basis of our earlier
findings (28), we considered the possibility that these NK cells had
recombined the floxed Dd gene but were H-2Dd positive because of
Ly49A-mediated uptake from surrounding cells. Indeed, NK cell
culture at a low density for 3 d resulted in the complete loss of
H-2Dd when Ly49A NK cells were derived from Ncr-cre Dd mice.
In contrast, H-2Dd expression was stably maintained on NK cells
from CD4-cre Dd mice (Fig. 1C).
We determined the function of NK cells by assessing the rejec-
tion of target cells in vivo. Mixtures of H-2b and Dd splenocytes,
which had been labeled with a high and a low concentration of
CFSE, respectively, were injected i.v. into poly IC–primed recipient
mice. As expected, Dd mice efficiently rejected H-2b (CFSE high)
splenocytes (Fig. 1D, 1E), and this depended on the presence of
NK1.1+ cells (Supplemental Fig. 1A). In contrast, rejection of H-2b
















splenocytes by Ncr-cre Dd and CD4-cre Dd mice was inefficient
and not different from that by littermate mice (Fig. 1D, 1E). De-
spite the presence on all other cell types, the lack of H-2Dd on
either NK cells or T cells prevented the NK cell–mediated rejection
of H-2b targets. In contrast, all mouse strains efficiently rejected
splenocytes that lacked all MHC-I molecules (Fig. 1F), demon-
strating that cell type–specific H-2Dd ablation does not globally
impair NK cell function.
We further determined whether T cell and NK cell–specific H-
2Dd ablation exerted a comparable negative effect on NK cell
function. To this end, we limited the abundance of Dd-deficient
T cells by reconstituting lethally irradiated Dd mice with various
mixtures of Dd and CD4-Cre Dd BM precursors. After stable
engraftment for .8 wk, we first verified that recipient mice
contained the expected percentage of Dd-negative T cells (Fig.
2A) and then determined the ability of NK cells to reject H-2b
target cells in vivo. The presence of .10% of Dd-negative T cells
in chimeric mice significantly impaired NK cell–mediated rejec-
tion of H-2b targets. However, once the fraction of H-2Dd–nega-
tive T cells was ,10%, there was no longer a significant adverse
effect on NK cell mediated rejection of H-2b targets (Fig. 2B). Of
note, the absolute number of Dd-negative cells present in these
latter mice was similar to that in Ncr-Cre Dd mice, which indi-
cated that NK cell–specific Dd deletion had a more profound
negative effect on NK cell function than T cell–specific deletion.
Moreover, the data showed that the negative effect seen in Ncr-Cre
Dd mice could not be explained by the presence of a small pop-
ulation of Dd-negative cells.
We next sought to corroborate the in vivo rejection results at the
single-cell level and to determine which NK cell subsets were
affected. We compared the response of NK cell subsets that were
defined by the expression of the Dd-specific Ly49A and the H-2b–
specific Ly49C, Ly49I, and NKG2A receptors (Fig. 3A). When
comparing H-2b to Dd NK cells from poly IC–primed mice, only
the NK cell subset from Dd mice that expressed Ly49A and lacked
Ly49C, Ly49I, and NKG2A receptors (Ly49A+CIN2 NK cells)
responded significantly to H-2b (RMA) target cells (Fig. 3B–D).
Ly49A+CIN2 NK cells from Dd mice efficiently released LAMP-1
and produced IFN-g in response to RMA (H-2b) (Fig. 3B–D) or
RMA/S tumor target cells (MHC-Ilow) (Supplemental Fig. 1B) but
FIGURE 1. Both NK cell and T cell–specific H-2Dd deficiency impairs
NK cell function. (A) H-2Dd expression was analyzed on T cells, B cells,
dendritic cells (DC), and NK cells from Dd mice and compared with those
of Ncr-Cre Dd (top panel) and CD4-Cre Dd mice (bottom panel). The
expression of H-2Dd relative to Ly49A was analyzed on freshly isolated
NK cells (B) and following a 3-d culture in IL-2 (C). Numbers indicate the
percentage of cells in the respective quadrant. (D) Mixtures of H-2b and Dd
splenocytes, which were labeled with a high and a low concentration of
CFSE, respectively, were injected i.v. into recipient mice, which had been
primed with poly IC 24 h before. Numbers in histograms depict the relative
abundance of CFSEhi (H-2b) cells in spleens of the indicated recipient
mice, 24 h after cell injection. (E) Specific rejection of H-2b splenocytes by
the indicated recipient mice. The bar graphs show the mean percentage of
rejection 6 SD from 3 to 15 mice per strain. ***p , 0.001. ns, Not sig-
nificant (p . 0.05). (F) Specific rejection of b2m-knockout (ko) spleno-
cytes by the indicated recipient mice. The bar graphs show the mean
percentage of rejection 6 SD from two to five mice per strain.
FIGURE 2. NK cells are not tolerized by a small fraction of Dd-deficient
T cells. (A) Lethally irradiated Dd mice were reconstituted with variable
mixtures of Dd and CD4-Cre Dd BM precursors as indicated. After stable
reconstitution, the percentage of Dd-negative cells was determined among CD4
T cells. (B) The reactivity of NK cells in recipient mice was assessed using
in vivo lysis assays as described in Fig. 1F. The bar graphs show the mean
percentage of rejection 6 SD from three to five mice per strain. **p , 0.01.
















not in response to H-2Dd–transfected RMA cells (Supplemental
Fig. 1C). In contrast, Ly49A+CIN2 NK cells from Ncr-cre Dd and
from CD4-cre Dd mice responded poorly to stimulation with RMA
(Fig. 3B–D) or with RMA/S cells (Supplemental Fig. 1B). In
contrast Ly49A+CIN+ NK cells from these mice responded to
RMA/S cells, indicating a specific impairment of the Ly49A+CIN2
population. The functional deficit was not due to deficient priming,
because poly IC injection resulted in a comparable upregulation of
CD69 and granzyme B expression by Ly49A+CIN2 NK cells of all
mouse strains (Supplemental Fig. 2A). Moreover, pharmacological
stimulation using PMA plus ionomycin resulted in comparable
effector responses (Supplemental Fig. 1D). Thus, NK cell and
T cell–specific Dd deletion had a similar adverse effect on NK
cell function.
To address the basis for the defect, we stimulated NK cells via
a defined activation receptor. As expected, Ly49A+CIN2 NK cells
from Dd mice responded significantly better than those from H-2b
mice (Fig. 3E, 3F). In contrast, when Dd was ablated from NK
cells (in Ncr-Cre Dd mice), the effector response was not increased
compared with littermate mice (Fig. 3E, 3F). When Dd was ab-
lated from T cells (CD4-Cre Dd mice), LAMP-1 release was also
not increased, but IFN-g production was increased compared with
littermate mice (Fig. 3E, 3F). Although the defect of CD4-Cre Dd
NK cells may not be completely explained by deficient licensing,
the defect of Ncr-Cre Dd NK cells can be.
Modifications of the MHC-I receptor repertoire upon cell
type–specific H-2Dd deletion
We assessed whether cell type–selective Dd deletion impacted
additional aspects of the NK cells adaption to self–MHC-I such as
the modification of the MHC-I receptor repertoire. The introduc-
tion of a Wt Ly49ATg into H-2Dd mice significantly modified the
endogenous MHC-I receptor repertoire (Fig. 4A, first row). Spe-
cifically, the abundance of NK cells expressing the inhibitory
Ly49G2 and Ly49I and the activating Ly49D and Ly49H recep-
tors were reduced, whereas that of CD94 and NKG2A, which form
the inhibitory CD94/NKG2A heterodimer, was expanded (Fig.
4A). Overall, we noted significant changes (p , 0.05) in seven of
the nine receptors or subunits that we analyzed (78%). In contrast,
Ly49A Tg expression in Ncr-cre Dd mice resulted in limited rep-
ertoire changes (three of eight receptors [38%]) (Fig. 4A). In
contrast, Ly49A Tg expression in CD4-cre Dd mice resulted in
abundant repertoire changes (six of eight receptors [75% changes])
(Fig. 4A), which essentially corresponded to those seen in Ly49A
Tg Dd mice. T cell–selective Dd deletion thus dissociated the
phenotypic from the functional adaptation of NK cells, whereas
NK cell–specific Dd deletion impaired both repertoire and func-
tional adaptation. Cell type–specific Dd deficiency had no signifi-
cant additional effects on the abundance (Supplemental Fig. 2B,
2C) and/or on the maturation of Ly49A+CIN2 NK cells.
FIGURE 3. Cell type–specific H-2Dd ablation impacts the function of
a specific NK cell subset. Splenocytes from the indicated strains of mice,
which had been primed with poly IC 24 h before, were exposed to RMA
cells (H-2b) for 4 h (A–D) or simulated with anti-NK1.1 (E, F). NK cells
(NK1.1+CD32) expressing Ly49A but lacking Ly49C, Ly49I, and NKG2A
receptors (Ly49A+CIN2) (A) were analyzed for the surface expression
of LAMP-1 and for intracellular IFN-g (B–F). Each panel represents the
mean 6 SD of at least three independent experiments. Groups differed
significantly as shown (*p , 0.05, **p , 0.01).
FIGURE 4. Modifications of the endogenous MHC-I receptor reper-
toire. Splenic CD32NK1.1+ NK cells from the indicated mice were ana-
lyzed for the expression of inhibitory MHC-I receptors (endogenous Ly49A,
Ly49C/E, Ly49F, Ly49G2, Ly49I, and CD94/NKG2A) and activating
Ly49 receptors (Ly49D and Ly49H). Data are shown as heat maps, which
depict differences in the size of specific NK cell subsets between non-Tg
Dd mice and mice expressing a Wt Ly49A Tg without or with cell type–
specific Dd ablation (A) or expressing the (trans only) A72, the (cis only)
Δa1, or the (ITIM mutant) Y8F Ly49A Tg (B). Data are from 4 to 20
independent determinations. Open squares indicate no difference (p .
0.05). Orange and red depict significantly decreased frequencies of p ,
0.05 and p , 0.01, respectively. Light green and dark green depict sig-
nificantly increased frequencies of p , 0.05 and p , 0.01, respectively.
nd, Not determined.
















Generation and analysis of Ly49A Da1 transgenic mice
To confirm the roles for cis versus trans recognition for NK cell
education, we used the transgenic expression of Ly49A receptor
variants with distinct Dd-binding properties. We have previously
analyzed an Ly49A variant (A72), containing a rigid stalk, which
failed to bind H-2Dd in cis but retained trans binding. Even though
this receptor variant inhibited NK cell effector function, it was
unable to license NK cells (9), suggesting that cis binding was
necessary to improve the responsiveness of NK cells. To indepen-
dently test this hypothesis, we took advantage of another Ly49A
variant with a deletion of the a1 element (aa 70–90) in the stalk
region (Ly49A Da1) (Fig. 5A), which interacted with MHC-I in cis
but failed to inhibit effector function based on the analysis of
transfectants (29). We generated Ly49A Da1 Tg mice (Fig. 5B)
that were backcrossed to B6 (H-2b) and to H-2Dd Tg B6 back-
grounds, respectively. Primary NK cells were used to confirm that
this receptor variant failed to productively interact with H-2Dd
expressed on other cells (Fig. 5C). We have previously shown that
a minimal length of the stalk, and not some other function of the
a1S segment, was critical for inhibitory Ly49A receptor function
(29). It is thought that inhibitory receptors must be coengaged
with activating NK cell receptors in submicroscopic clusters to
antagonize activation signaling (30). According to the concept of
size-based segregation (31, 32), activating and inhibitory recep-
tor–ligand pairs need to fit into the synaptic cleft of 100–150 Å
between the NK cell and the target cell membrane. Activating and
inhibitory interactions may become mutually exclusive when the
Ly49A stalk is too short. We next confirmed that the Da1 receptor
retained the capacity to bind H-2Dd in cis. Da1 Tg NK cells bind
soluble H-2Dd ligand, and this binding was reduced (2-fold)
when NK cells were from H-2Dd as compared with B6 mice
(mean fluorescence intensity [MFI] of gray histograms) (Fig. 5D).
This was due to receptor masking, because the binding of soluble
H-2Dd significantly increased following acid-mediated disrup-
tion of MHC-I complexes on living NK cells from H-2Dd mice
(compare the MFI of gray to the open histograms) (Fig. 5D) (14).
Thus, in agreement with our previous analyses (29), these data
confirm that the Ly49A Da1 receptor binds H-2Dd in cis but fails
to functionally bind in trans.
Our previous analyses have shown that, unexpectedly, Wt Ly49A
suppressed cytokine production in H-2b mice (i.e., when H-2Dd was
absent (9)), indicating that unengaged receptors have a suppressive
effect. Because the coexpression of MHC-I receptors modified the
NK cell response (9), we determined the effect of the different
Ly49 Tgs in the absence of endogenous MHC-I receptors. To this
end, we focused on the small NK cell subset, which lacks all
known MHC-I receptors in B6-background mice (Ly49AB6, C, D,
F, G2, H, I, and NKG2A/CD94), termed null NK cells (1–2% of
NK cells) (Fig. 6A). The use of the BALB allele of Ly49A to
generate Tg mice allowed the exclusion of NK cells expressing
endogenous Ly49AB6 (mAb A1+). Null NK cells expressed the
various Tg Ly49A receptors (Fig. 6A), allowing us to determine the
impact of Tg expression on NK cell responsiveness.
As expected, NK1.1 mAb-induced IFN-g production by null NK
cells from non-Tg control mice was inefficient (Fig. 6B, 6C). The
coexpression of H-2Dd and the Wt Ly49A receptor significantly
improved IFN-g production (Fig. 6B, 6C). In contrast, the A72
receptor (trans only) failed to improve IFN-g production (Fig.
6C), in agreement with our lysis data (9). Similarly, the Da1 re-
ceptor (cis only) failed to improve IFN-g production by null NK
cells (Fig. 6B, 6C). NK cell stimulation by pharmacological
means, rather than via cell surface receptors, resulted in compa-
rable IFN-g production by all types of transgenic NK cells (Fig.
6D). These data suggested that exclusive cis and trans interactions
were both not sufficient for the functional adaptation of NK cells.
This result was consistent with the outcomes of NK cell and T cell
type–specific Dd deletion.
We also analyzed NK cells from mice expressing a Tg Ly49A
receptor with a mutated ITIM (Ly49AY8F). This receptor retained
the ability to bind H-2Dd in cis and in trans but did not inhibit NK
cell effector function (9). However, the expression of this receptor
did not improve IFN-g production (Fig. 6D) in agreement with (7).
Thus, the functional adaptation of NK cells to MHC-I depended on
an intact ITIM.
Modifications of the MHC-I receptor repertoire by transgenic
Ly49A receptors
We next investigated whether Ly49A Tg expression impacted NK
cell development and maturation. Ly49A Tg expression did not
significantly alter the number of splenic or BM NK cells (Supple-
mental Fig. 3) or the expression of markers of NK cell differen-
tiation and maturation (including KLRG1, CD11b, and CD27)
FIGURE 5. Generation of mice expressing a transgenic Ly49A Da1
receptor. (A) Schematic representation of the Wt and Ly49A Δa1 receptors,
highlighting the ligand binding Ly49A NK domains (NKD) (dark gray) and
the known (a3) and predicted (a2 and a1) a-helical segments of the stalk.
The membrane proximal a1 segment (light gray) was deleted to generate
the Ly49A Δa1 receptor. (B) Density plots show the abundance of CD32
NK1.1+ NK cells in the spleen of mice expressing a Wt or the Da1 Ly49A
receptor Tg on a H-2b background. Histograms show Ly49A expression
(mAb JR9) in gated NK cells. Numbers indicate the MFI of Ly49A staining.
(C) The inhibitory capacity of the Ly49A Da1 receptor was tested in lysis
assays with cytokine-activated effectors against C1498 (top panel) and
C1498 Dd tumor targets cells (bottom panel). Data represent means 6 SD
of triplicate determinations at the indicated E:T cell ratios. (D) Splenocytes
from the indicated types of mice were exposed to an acidic buffer to
disrupt MHC-I–peptide complexes. Gated CD32NK1.1+ NK cells were
further stained with mAbs to b2m or Ly49A or with D
d multimer. Filled
gray histograms depict the staining before and open histograms after acid
stripping. Numbers indicate the MFI of staining with Dd tetramer.
















(data not shown), in agreement with our previous analyses (9).
Finally, we addressed whether Tg Ly49A receptors modified the
repertoire of endogenous MHC-I receptors used by NK cells. As
shown above, the expression of the Wt Ly49A Tg resulted in
abundant repertoire changes (78% of analyses) (Fig. 4A). In con-
trast, the expression of the ITIM mutant Y8F Tg did not modify the
receptor repertoire (zero of nine analyses) (Fig. 4B). Thus, signaling
via the ITIM is essential for the functional (Fig. 6D) (7) and for the
phenotypic adaptation of NK cells. The expression of the 72A Tg
(trans only) had very limited effects on endogenous MHC-I receptor
usage (two of nine analyses, 22%) (Fig. 4B). This outcome corre-
sponded to the impact of NK cell–specific Dd deletion (Fig. 4A).
Thus, trans interactions do neither adapt the repertoire nor the
function of NK cells. In contrast the (cis only) Ly49A Δa1 Tg re-
ceptor significantly skewed the endogenous MHC-I receptor reper-
toire (67% of analyses) (Fig. 4B). This result corresponded to that
obtained in CD4-Cre Dd mice (Fig. 4A), where cis interactions
occurred and trans interactions were intermittent. These data sug-
gest that cis interaction was sufficient to shape the receptor reper-
toire but that both cis and trans interactions were needed to produce
functional NK cells.
Discussion
The finding that both cis and trans binding are necessary for the
functional adaptation of NK cells raises the possibility that the two
types interactions serves distinct functions. An important role for
trans interaction has been established based on the adoptive transfer
of fully mature NK cells. Trans interactions protect mature NK cells
from the adverse effects of chronic stimulation (33). A similar effect
may explain the functional deficit of NK cells that mature in CD4-
Cre Dd mice. The precise role of cis interaction remains to be
established. However, because there is no evidence that it is inhib-
itory, it may not serve to protect NK cells from chronic stimulation.
Further along these lines, it may be interesting to consider the
modifications of the MHC receptor repertoire. These generally
correlate with, and may thus be a by-product, or the consequence of
functional maturation. If repertoire modifications are indeed a by-
product of functional adaptation, then, based on its prominent role to
skew the repertoire, cis interaction may render NK cell activation
receptors responsive. The enhanced NK cell activation levels may
lead to adaptations of the receptor repertoire. Then, if MHC-I
receptors interacted only in cis but could not productively or con-
tinuously interact in trans, NK cells would not be protected from the
adverse effects of chronic stimulation and activation receptors may
eventually be desensitized. According to this model, cis engagement
of MHC-I receptors would instruct NK cell activation receptors to
become responsive and trans engagement would protect NK cells
from exhaustion. Consistent with this notion, individual NK cells
can at the same time recognize MHC-I in cis and in trans, because
not all MHC-I receptors are engaged in cis. Although available data
are consistent with such a scenario, additional experimentation will
be required to rigorously test this model.
With regard to the role of MHC-I expression in trans, our ex-
perimental setup provides evidence that the absence of MHC-I
from surrounding T cells is sufficient to impair NK cell fitness
in vivo. These data confirm and extend findings based on mixed
bone marrow chimeras (33, 34) (Fig. 2; our unpublished data),
MHC-I mosaic mice (20, 35) and the adoptive transfer of mature
NK cells (18). The novel information provided by our analyses is
that the absence of MHC-I from a single, defined cell type, as
opposed to a fraction of all hematopoietic cell types, is sufficient
to impair NK cell fitness. It will be of interest to address whether
all cell types have this capacity or whether T cells are particularly
potent to stimulate NK cells.
We further show that MHC-I expressed by NK cells plays an es-
sential role for their function. These results contrast with adoptive
FIGURE 6. Responsiveness of Ly49ATg NK cells. (A) Identification of
“null” NK cells (CD32NK1.1+) that lack all known MHC-I receptors in
B6-background mice (Ly49+NKG2: Ly49A [mAb A1], C, D, F, G2, H, I,
and NKG2A/CD94). The NK cell subset expressing endogenous Ly49AB6
(mAb A1+) could be excluded from the analysis because of the use of the
BALB allele for all Ly49A transgenic receptors. Filled gray histograms
depict Ly49A expression among “null” NK cells from non-Tg mice. Open
histograms depict the expression of the Wt or the Δa1 (cis only) Ly49ATg
receptor in null NK cells. Numbers indicate the percentage of cells in the
respective gate. (B) Total spleen cells from the indicated types of mice on
a H2bDd background were stimulated with immobilized NK1.1 mAb (anti-
NK1.1) or left unstimulated (No) in the absence of cytokine addition.
Numbers indicate the percentage of null NK cells producing IFN-g. (C)
The bar graph depicts the mean percentage (6SD) of IFN-g–positive null
NK cells from mice expressing the Wt, the A72 (trans only), the Δa1 (cis
only), or the Y8F (ITIM mutant) Ly49ATg on a H-2b and on a H-2b Dd (Dd)
background. (D) The bar graph shows the mean percentage (6SD) of
IFN-g–positive null NK cells from the indicated type of mice after
stimulation with PMA plus ionomycin. pp , 0.05. ns, Not significantly
different (p . 0.05) (n = 3–7).
















NK cell transfer studies, which found that the function of MHC-I–
deficient NK cells improved following their transfer into a
MHC-I–sufficient environment (18, 19). These data suggested
that MHC-I expression by NK cells was not essential to improve
NK cell function. However, there are important differences between
the experimental approaches, which may account for the distinct
outcomes. Cell transfers generated transient states and addressed the
behavior of peripheral NK cells that, to our knowledge, encountered
MHC-I for the first time. In contrast, we assessed the function of
peripheral NK cells under steady-state conditions, and these cells
were exposed to MHC-I during their development in the bone
marrow. Thus, the developmental stage may impact how NK
cells adapt to MHC-I encounter or loss. Consistent with this notion,
we observed significant changes in MHC-I receptor usage (per-
centage of positive cells), which was not evident upon adoptive
transfer of peripheral NK cells (18). Whatever the precise reason for
the distinct outcomes, we can at least exclude one possible mecha-
nism for the functional adaptation in a MHC-I mosaic environment:
MHC-I–deficient NK cells can acquire significant quantities of
MHC-I molecules (up to 15%) from surrounding cells via their Ly49
receptors, which reduces the Ly49 MFI (28, 36). It was proposed that
this process may improve NK cell function in the transfer setting
(19). Uptake of H-2Dd from surrounding cells was also observed in
Ncr-Cre Dd mice; however, the respective NK cells were not func-
tional. Thus MHC-I uptake from surrounding cells does not seem to
be sufficient to establish functional competence. Rather, MHC-I gene
expression by NK cells is important for their functional maturation.
The analysis of NK cell function in MHC-I mosaic situations is
of relevance for the understanding of the behavior of donor-derived
NK cells that arise in leukemia patients receiving allogeneic stem
cell transplantation. Recipients of HLA haploidentical stem cell
transplants reportedly benefit from a graft-versus-leukemia effect
mediated by NK cells when leukemia cells express HLA class I
alleles that are not engaged by killer Ig–related receptor (KIR) of
the donor (KIR ligand mismatch) (37–39). However, because of
the HLA mosaic situation in the recipient, it is not obvious how
donor-derived NK cells become competent to kill leukemic cells.
According to the disarming model, recipient HLA should exert
a dominant-negative role on NK cell function. One possible ex-
planation for the positive role of donor HLA is that donor-type
HLA molecules play an instructive role for NK cell licensing. If
so, KIR may also educate NK cells based on the HLA molecules
expressed by the NK cells themselves.
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8. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso,
C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by
inhibitory receptors for MHC class I. Immunity 25: 331–342.
9. Chalifour, A., L. Scarpellino, J. Back, P. Brodin, E. Devèvre, F. Gros, F. Lévy,
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killer cell tolerance in mice with mosaic expression of major histocompatibility
complex class I transgene. J. Exp. Med. 186: 353–364.
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